|
|
Clinical significance of p16 protein expression in cervical intraepithelial neoplasia Ⅱ |
HUANG Liping LIN Xia▲ |
Department of Gynaecology, Zhongshan Boai Hospital Affiliated to Southern Medical University, Guangdong Province, Zhongshan 528400, China |
|
|
Abstract Objective To observe the expression of p16 protein in the tissues of patients with different cervical lesions, and to investigate the feasibility of p16 protein as a reference index of CIN Ⅱ. Methods From January 2013 to August 2015, 170 cases underwent colposcopy and biopsy in Zhongshan BOAI Hospital Affiliated to Southern Medical University proved cervicitis, CIN Ⅰ and CIN Ⅱ, CIN Ⅲ and four cervical carcinoma group were selected, the expression of p16 were observed in different cervical lesions by p16 immunohistochemical staining, efficiency of the test of p16 protein in the diagnosis of CIN Ⅱ and above statistic (CINⅡ+, including CIN Ⅱ, CIN Ⅲ and cervical cancer) performance. And 170 cases of CIN Ⅱ patients were followed up every six months until 2 years after diagnosis with abnormal colposcopic biopsy, the relationship between the expression of p16 and outcome measures of CIN Ⅱ patients lesions was analyzed. Results ①The p16 positive rates of the cervicitis group and CIN Ⅰ group and CIN Ⅱ group, CIN Ⅲ and cervical cancer groups were 3.53%, 41.18%, 81.18%, 100% respectively, the difference was statistically significant (P < 0.05); the positive rate of p16 protein in the CINⅡ group was significantly higher than that of cervicitis group and CIN Ⅰ group, the differences were statistically significant (P < 0.01), the positive rate of p16 protein in the CIN Ⅲ group and cervical cancer group were significantly higher than CINⅡ group, CINⅠgroup, cervicitis group, the differences were statistically significant (P < 0.01). ②The sensitivity, specificity, coincidence rate, positive predictive value and negative predictive value of p16 protein in the detection of CINⅡ+ were respectively 90.59%, 77.65%, 84.12%, 80.21% respectively, 89.19%. ③62 cases (44.93%) in 138 CIN Ⅱ patients with positive expression of p16 protein had abnormal follow-up, 3 cases (9.38%) of 32 cases of disease progression CIN Ⅱ patients with negative expression of p16 protein had abnormal follow-up, the difference of two were statistically significant (P < 0.05). Conclusion The positive rate of p16 protein increased with the severity of cervical lesions. Detection of p16 protein shows better sensitivity, specificity, coincidence rate, positive predictive value and negative predictive value in the detection of CINⅡ+. The expression of p16 protein can predict the progression of CIN Ⅱ disease, and can be applied to the shunt of CIN Ⅱ in clinic.
|
|
|
|
|
[1] Kava S,Rajaram S,Arora VK,et al. Conventional cytology,visual tests and evaluation of P16(INK4A) as a biomarker incervical intraepithelial neoplasia [J]. Indian J Cancer 2015,52(3):270-275.
[2] Gustinucci D,Passamonti B,Cesarini E,et al. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within anorganized cervical cancer screening program [J]. Acta Cytol,2012,56(5):506-514.
[3] 郭宇雯,吴正升,张和平,等.子宫颈上皮内瘤变及子宫颈癌组织中 p16和 TLR3的表达及意义[J].临床与实验病理学杂志,2015,31(5):502-505.
[4] 王泊云,李玉松,黄高昇,等.病理学技术[M].北京:人民卫生出版社,2001:80-81.
[5] 王荣敏,李雪洁,钱敏,等.CINⅠ的转归及p16INK4a蛋白表达在分流CINⅠ中的临床意义[J].中华妇产科杂志,2015,50(3):210-215.
[6] 金蓉蓉,马红伟,陈天羽,等.P16/Ki67双染检测在意义不明的不典型鳞状细胞分流诊断中的作用[J].中华病理学杂志,2017,46(7): 481-484.
[7] Rokita W,Skawiński D,Zmelonek-Znamirowska A,et al. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer [J]. Ginekol Pol,2012,83(11):822-826.
[8] 卢朝辉,陈杰.WHO女性生殖器官肿瘤学分类(第4版)解读[J].中华病理学杂志,2014,43(10):649-650.
[9] Varadarajan I,Basu A,Besmer S,et al. Solitary Skeletal Muscle Metastasis as First Site of Recurrence of Cervical Cancer:A Case Report [J]. Case Rep Oncol,2017,10(2):694-698.
[10] Carozzi F,Gillio-Tos A,Confortini M,et al. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results:a prospective analysis of a nested substudy of the NTCC randomised controlled trial,2013,14(2):168-176.
[11] Moleriu LC,Sas I,Ra■iu AC,et al. HPV genotyping and p16-Ki-67 dual staining in the detection of high-gradecervical lesion in patients with LSIL on Pap smear [J]. Rom J Morphol Embryol,2017,58(2):433-437.
[12] Stewart CJR. High-grade squamous intraepithelial lesion (HSIL) of the cervix with bizarre cytological appearances ('pleomorphic HSIL'):a review of 19 cases [J]. Pathology,2017,49(5):465-470.
[13] Xing Y,Wang C,Wu J. Expression of geminin,p16,and Ki67 in cervical intraepithelial neoplasm and normal tissues [J]. Medicine (Baltimore),2017,96(26):e7302.
[14] Li RN,Li CY,Lee CH,et al. Promoter methylation status of the tumor suppressor genes p16 and cadherin 1 incervical intraepithelial neoplasia [J]. Oncol Lett,2017,13(6):4397-4401.
[15] Silva DC,Goncalves AK,Cobucci RN,et al. Immunohistochemical expression of p16,Ki-67 and p53 in cervical lesions-A systematic review [J]. Pathol Res Pract,2017, 213(7):723-729.
[16] Tong R,Yang Q,Wang C,et al. OVCA1 expression and its correlation with the expression levels of cyclin D1 andp16 in cervical cancer and intraepithelial neoplasia [J]. Oncol Lett,2017,13(5):2929-2936.
[17] Ziemke P. p16/Ki-67 Immunocytochemistry in Gynecological Cytology:Limitations in Practice [J]. Acta Cytol,2017,61(3):230-236.
[18] Singh C Manivel JC,Truskinovsky AM,et al. Variability of pathologists' utilization of p16 and ki-67 immunostaining in the diagnosis of cervical biopsies in routine pathology practice and its impact on the frequencies of cervical intraepithelial neoplasia diagnoses and cytohistologic correlations [J]. Arch Pathol Lab Med,2014,138(1):76-87.
[19] 于静,朱慧庭,赵晶晶,等.p16INK4a/Ki-67双免疫细胞化学染色对宫颈细胞学不能明确意义的不典型鳞状细胞和低级别鳞状上皮内瘤变患者的分流作用[J].中华病理学杂志,2017,46(5):323-326.
[20] 王兴民,王鑫丹,庞朗,等.P16联合Ki-67免疫组化检测在宫颈病理诊断中的应用[J].中国医学创新,2016, 13(29):48-51.
[21] Mills AM,Dirks DC,Poulter MD,et al. HR-HPV E6/E7 mRNA In Situ Hybridization:Validation Against PCR,DNA In Situ Hybridization,and p16 Immunohistochemistry in 102 Samples of Cervical,Vulvar,Anal,and Head and Neck Neoplasia [J]. Am J Surg Pathol,2017,41(5):607-615.
[22] 王桂梅,聂美楠,王彩霞,等.p16和Ki-67在鉴别宫颈上皮内瘤变和宫颈炎中的应用[J].中国医学创新,2015, 12(19):149-151.
[23] 陈颖,林文毅,张凌,等.Bcl-2、P16及ki-67在宫颈原位腺癌中的诊断价值[J].西部医学,2017,29(9):1250-1254. |
|
|
|